LCBSG LIMITED

Company number 09209265 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: LCBSG Limited (Company No. 09209265)

Patient Profile

Before examining the numbers, context matters — this patient is not a typical trading business. LCBSG Limited is an intermediate holding company within a group headed by Project Hallelujah Bidco Limited. Per its filed accounts, its trading subsidiaries provide insolvency and restructuring services to financially struggling businesses. So a "zero turnover" reading is not a symptom of illness here — it is the patient's anatomy. The heart doesn't digest food; it pumps blood to the organs that do. Note clearly: the company itself is Active and not in any insolvency process — it advises on insolvency; it is not in it.


1. Financial Health Score: B-

Structurally sound, but running on a very thin pulse at the parent level. The company is solvent, compliant, and audited with an unqualified opinion. However, the FY2025 balance sheet shows a significant new liability load (£5.43m), minimal parent-level cash (£4,222), and total dependence on subsidiaries for income. As a standalone entity this would score lower; in its group context, with the accounts stating that operating cash generation keeps group borrowings at "a very manageable level", the grade settles at B-.


2. Key Vital Signs

Vital Sign Reading (FY2025) Interpretation
Net assets / solvency £10,204,321 Healthy. Positive equity, up £454,246 (+4.7%) on the prior year — value is accreting, not eroding
Liquidity (parent cash) £4,222 Anaemic. Cash has fallen from £48,116 (2021) to near-nil today. The parent runs on a shoestring
Leverage £5,431,810 liabilities vs £10.2m equity New condition. Gearing of roughly 53% of equity appeared in FY2025, versus effectively nil in FY2024
Revenue £0 Expected for a holding company — income arrives as dividends/returns from subsidiaries
Compliance health All filings current Excellent. Accounts to April 2025 filed well ahead of the January 2027 deadline; confirmation statement current
Audit status Audited, unqualified opinion Strong. Medium-entity accounts were voluntarily audited, and the auditors concluded the going concern basis is appropriate
Equity trend (7 years) £8.7m (2019) → £10.2m (2025) Stable, then growing. Equity was essentially flat around £9.75m from 2020–2024, indicating a passive holding period, before FY2025's step-change

Data note: liability figures appear in the raw data as negative values (a bookkeeping convention); they are interpreted here as positive amounts owed. Some prior-year fields are incomplete, so trend analysis relies on the equity and cash series.


3. Symptoms Analysis

  • The £5.4m liability is the headline symptom. The accounts' tagging shows both current and non-current "financial instruments", suggesting a mix of borrowings or loans — likely connected to the group bank facility the strategic report mentions, or funding pushed down to subsidiaries. This is the single biggest change in the patient's condition and the item most in need of a fuller work-up (terms, maturity, security, covenants).
  • Investment in subsidiaries increased (the accounts tag additions to investments), which — read together with the new liabilities and the £454k equity uplift — paints a picture of a group reorganisation: capital was raised and injected downward into the trading businesses.
  • Cash drained steadily at the parent: £48k (2021) → £38k (2022–2023) → £0 (2024) → £4k (2025). Not fatal for a holding company, but it means the parent has almost no independent buffer.
  • Board turnover: five directors served during FY2025; the current register shows four, following a resignation in January 2026 (that individual remains listed as a person with significant control, holding 25–50% of shares) alongside new appointments. Governance transitions like this often accompany group restructurings — worth monitoring, not alarming in itself.
  • No dividend was paid, per the directors' report — consistent with cash being retained or reinvested lower down the group.

4. Diagnosis

A solvent, well-run holding company whose vital functions are delegated to its subsidiaries. The balance sheet is fundamentally healthy — £10.2m of net assets against £5.4m of liabilities, with no signs of distress: no insolvency proceedings, no overdue filings, and auditors satisfied on going concern. The "low blood pressure" is the parent's own liquidity: with £4,222 of cash and a £5.4m liability stack, the company cannot stand alone — it lives or dies on cash flowing up from the trading subsidiaries. The accounts state that the group generates healthy operating cash flow and uses its bank facility only at a manageable level, and the ultimate parent (Project Hallelujah Bidco Limited) owns more than 75% of the shares — but those claims can only be verified in the group's consolidated accounts, which sit outside this patient's chart.


5. Prognosis

Cautiously positive, with the usual caveat that this patient's health is inherited, not self-generated. The underlying business — insolvency and restructuring advisory — is notably counter-cyclical: demand tends to rise when the wider economy sickens, providing a natural hedge against downturns. The accounts identify the key risks as staff retention, competition for talent, and appropriate financing — classic service-business risks rather than balance-sheet pathologies. The main watch-points are the servicing of the newly introduced £5.4m in liabilities, the near-zero parent cash buffer, and any covenant conditions attached to the group facility.


6. Recommendations

  1. X-ray the £5.4m liability: obtain the full accounts and establish the split between amounts due within one year and beyond, the interest terms, and any security or covenants. This is the one symptom that cannot be assessed from the summary data alone.
  2. Build a parent-level cash buffer or secure committed facility access, so the holding company is not wholly reliant on the timing of subsidiary distributions to meet its obligations.
  3. Match debt maturities to upstream cash flows: schedule subsidiary dividends so repayment dates on the financial instruments are comfortably pre-funded.
  4. For anyone assessing this company as a counterparty: review the consolidated accounts of Project Hallelujah Bidco Limited — the real muscle, circulation, and cash generation of this group live there, not at this level.
  5. Maintain the excellent compliance discipline: timely, audited medium-entity accounts are a strong transparency signal and should be preserved.

Perspective: Financial Health Diagnostician · Model: glm-5.3 · Generated 19 November 2026